CXO industry receives favorable cooperation, with WuXi AppTec expected to receive new orders

2026-07-10 18:15

Economic Observation Network The biopharmaceutical companies bound to WuXi AppTec have reached overseas cooperation, catalyzing the CXO industry and increasing expectations for new orders from the company

Industry policies and environment:
The recent cooperation between Chinese biopharmaceuticals, AstraZeneca, and GSK is seen as an indirect benefit to the CXO industry, which may bring new order expectations to WuXi AppTec, which is deeply bound to these major customers

The above content is based on publicly available information and does not constitute investment advice.

Disclaimer: The views expressed in this article are for reference and communication only and do not constitute any advice.